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Abstract
Introduction: Anti-glomerular basement membrane disease is a rare autoimmune disorder characterized by
pulmonary hemorrhage, crescentic glomerulonephritis and the presence of circulating anti-glomerular basement
membrane antibodies. The simultaneous occurrence of both anti-glomerular basement membrane disease and
membranous nephropathy is rare.
Case presentation: A 59-year-old Hispanic man presented with acute onset of nausea and vomiting and was
found to have renal insufficiency. Work-up included a kidney biopsy, which revealed anti-glomerular basement
membrane disease with underlying membranous nephropathy. He was treated with emergent hemodialysis,
intravenous corticosteroids, plasmapheresis, and cyclophosphamide without improvement in his renal function.
Conclusion: Simultaneous anti-glomerular basement membrane disease and membranous nephropathy is very
rare. There have been 16 previous case reports in the English language literature that have been associated with a
high mortality and morbidity, and a very high rate of renal failure resulting in hemodialysis. Co-existence of
membranous nephropathy and anti-glomerular basement membrane disease may be immune-mediated, although
the exact mechanism is not clear.
Introduction
Anti-glomerular basement membrane (anti-GBM) dis-
ease is a rare autoimmune disorder with significant
morbidity and mortality and is characterized by pulmon-
ary hemorrhage, crescentic glomerulonephritis, and the
presence of circulating anti-GBM antibodies which bind
to the alpha-3 chain of type 4 collagen found in the glo-
merular and alveolar basement membranes [1]. The
etiology of anti-GBM disease is unclear, but may result
from hydrocarbon exposure; specific HLA molecules
have also been found to be associated with disease.
Anti-GBM disease accounts for approximately 10 to
20 percent of patients with rapidly progressive crescentic
glomerulonephritis in the United States. The diagnosis is
established by demonstration of high titers of anti-GBM
antibodies in the circulation and/or renal biopsy. Early
treatment with high-dose corticosteroids, plasmapheresis
and cyclophosphamide is recommended because early
and appropriate treatment may reverse the extent of
renal damage and potentially prevent the need for life-
long dialysis. In untreated patients, anti-GBM disease
progresses to renal failure and death. There have been
very few case reports documenting the simultaneous
appearance of anti-GBM disease and membranous
nephropathy. Here, we present a case of combined dis-
ease, and review the literature on this important, but
rare, condition.
Case presentation
A 59-year-old Hispanic man with no known significant
past medical history was well until two weeks prior to
presentation when he noted some chest congestion and
early morning nausea. One week later, he presented to a
local walk-in clinic where he was treated with hydroco-
done, chlorpheniramine (Tussionex), and ciprofloxacin
without improvement. Five days later, he presented to
our Emergency Department with complaints of nausea,
vomiting, fatigue, decreased urination, and generalized
malaise. He denied hemoptysis, hematuria, rash, or use
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of non-steroidal anti-inflammatory agents. He believed
that he had received a blood transfusion during the
Vietnam War secondary to bleeding after a forearm
injury. Physical examination revealed that his tempera-
ture was 98.2°F, pulse 88 per minute, respiratory rate
20 per minute, and blood pressure 160/78 mmHg.
Examination was otherwise unremarkable.
Laboratory studies revealed a serum creatinine of
25 mg/dL (normal range 0.6 to 1.2 mg/dL), BUN
175 mg/dL (normal range 5 to 21 mg/dL), hemoglobin
10 gm/dL (normal range 13.5 to 18 gm/dL), and hema-
tocrit 28.9% (normal range 41 to 54%). Urine analysis
showed proteinuria of over 300 mg, too numerous to
count red blood cells per high power field, and too
numerous to count white blood cells per high power
field; the urine was negative for eosinophils, red blood
cell casts and Bence Jones protein. Serum potassium
and phosphorus were 5.0 mg/dL and 9.4 mg/dL, respec-
tively. Serum albumin was 3.1 gm/dL (normal range 3.5
to 5.0 gm/dL). ANA, C-ANCA, P-ANCA, hepatitis
panel, and HIV antibody tests were negative. Serum pro-
tein electrophoresis, creatine phosphokinase, quantita-
tive Immunoglobin assay, complement levels and chest
radiograph were all normal. A renal ultrasound showed
that the kidneys were of normal size. He was started on
hemodialysis and methylprednisolone one gram intrave-
nously daily. Kidney biopsy revealed cellular crescents in
all 20 glomeruli seen on the biopsy specimen (Figure 1).
Immunofluorescent staining revealed linear glomerular
capillary wall positivity of 3+ intensity for IgG with C3,
3+ kappa and 2+ lambda (Figure 2), supporting the
diagnosis of anti-GBM disease. Electron microscopy
revealed global subepithelial deposits, diagnostic of
membranous glomerulopathy (Figure 3). The serum
anti-GBM antibody was positive with titer of over
100 units/mL. He was started on plasmapharesis, cyclo-
phosphamide and prednisone, and was maintained on
hemodialysis. There was no significant improvement in
his renal function. He is being maintained on hemodia-
lysis after six months following his initial presentation.
He is currently awaiting kidney transplantation.
Discussion
This case of co-existing anti-GBM disease and membra-
nous nephropathy is very rare. His biopsy showed 20
out of 20 glomeruli visualized revealing acute and severe
cellular crescents on light microscopy. Immunofluoros-
cence staining revealed linear glomerular capillary wall
positivity of 3+ intensity for IgG with 1-2+ C3, 3+
kappa and 2+ lambda, supporting the diagnosis of anti-
GBM disease. In addition, electron microscopy revealed
subepithelial global deposits, diagnostic of membranous
Figure 1 Light microscopy revealed cellular crescents in all
sampled 20 glomeruli with extensive fibrinoid necrosis and
neutrophil margination.
Figure 2 Immunofluorescence findings of linear glomerular
capillary wall positivity of 3 + intensity for IgG with 1-2+ C3,
3+ kappa and 2+ lambda support the diagnosis of anti GBM
disease.
Figure 3 Electron microscopy showed global subepithelial
deposits which is diagnostic for underlying membranous
glomerulopathy stage 3.
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glomerulopathy. The findings of membranous glomeru-
lopathy were chronic and predated the development of
anti-GBM disease. He presented with an unusually high
serum creatinine of 25 mg/dL, consistent with extensive
renal damage at the time of presentation.
A review of the literature revealed 16 previously
reported cases. (Table 1) [2-16]. The mean age of the
patients was 46 years (range 19 to 65 years), with a pre-
dominance of men (11 cases). Four patients had pul-
monary involvement in the form of Goodpasture’s
syndrome at the time of presentation. The mean serum
creatinine level at presentation was 8.8 mg/dL (range
0.7 to 25 mg/dL). Eight patients presented with edema,
three with hemoptysis, two with cough, two with hema-
turia, and one patient had fever and a sore throat; our
patient presented with nausea and oliguria. The out-
come was poor as four patients died and nine patients
remained on hemodialysis despite treatment with corti-
costeroids and plasmapheresis. Only three patients had
a good prognosis without the need for hemodialysis; of
these patients, the serum creatinine on presentation was
1.2 mg/dL, 3.0 mg/dL and 0.7 mg/dL, indicating that
these patients had less renal damage. Five of the patients
who initially had membranous nephropathy followed by
anti-GBM disease were middle aged to elderly, in con-
trast to five cases of anti-GBM disease preceding mem-
branous nephropathy in which all were young adults
[15]. Savige et al. also reported six patients with both
anti-GBM disease and membranous nephropathy, all of
whom were treated with steroids, cyclophosphomide
and plasmapheresis. Five of the six patients were
between the ages of 15 to 22 years and recovered well;
another patient was 47 years old and remained dialysis
dependent [17]. Interestingly, in these younger patients,
hematuria and/or hemoptysis were the presenting symp-
toms, in contrast to the middle age group who initially
presented with edema consistent with membranous glo-
merulonephritis, followed by anti-GBM disease. The
proteinuria ranged from trace to 20.7 gm/24 hr, depend-
ing on extent of renal damage.
Immunologic mechanisms involved in the pathogen-
esis of anti-GBM disease may directly or indirectly lead
to the genesis of membranous-type deposits. It is possi-
ble that the intramembranous and epimembranous
immune complexes found in membranous nephropathy
alter the glomerular basement membrane, causing
release of normal or altered glomerular basement mate-
rial with subsequent development of anti-GBM antibo-
dies and crescentic glomerulonephritis. Induced
autoimmune disease in brown Norway rats with mercu-
ric chloride demonstrated initial anti-GBM disease with
linear immunoglobulin deposit formation together with
formation of autoantibodies directed against multiple
basement membrane proteins and proteoglycan
Table 1 Characteristics of 17 patients with combined anti-GBM disease and membranous nephropathy
Case Number
[ref #]
Age/Sex Initial serum creatinine (mg/
dL)
Clinical presentation Treatment Outcome
1 [2] 49/M 18.0 Edema Steroids Died
2 [3] 53/M 13.0 Edema Steroids, azathioprine Hemodialysis
3 [3] 44/M 3.1 Edema Steroids Hemodialysis
4 [4] 20/F 1.2 Cough, syncope None Survived
5 [5] 19/F 10.5 Hemoptysis Steroids (p)*, azathioprine,
nephrectomy
Hemodialysis
6 [6] 25/M 2.1 Hemoptysis Steroids, PP** Died
7 [7] 65/M 4.0 Edema Steroids, PP, cyclophosphamide Died
8 [8] 20/M 3.0 Fever, sore throat, lumbar
pain
Steroids, PP Survived
9 [9] 54/M 1.1 Cough, arthralgia Steroids, PP Hemodialysis
10 [10] 60/M 19.5 Fatigue, anorexia, edema Steroids (p), PP Hemodialysis
11 [11] 57/not
reported
11.8 Fatigue, hemoptysis Steroids (p), PP, cyclophosphamide Hemodialysis
12 [12] 50/M 0.7 Edema Steroids (p), PP, cyclophosphamide Survived
13 [13] 50/F 8.9 Edema, nausea Steroids (p), PP Hemodialysis
14 [14] 54/F 8.9 Hematuria Steroids, PP Hemodialysis
15 [15] 49/M 7.3 Hematuria, flank pain,
fatigue
Steroids, PP, cyclophosphamide Hemodialysis
16 [16] 50/F 11.6 Edema Steroids, PP, cyclophosphamide Hemodialysis
17 (present
case)
59/M 25.0 Fatigue, oliguria, nausea Steroids, PP, cyclophosphamide Hemodialysis
PP, plasmapheresis; p, pulse steroid therapy
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components [18]. Membranous deposits may subse-
quently arise from in situ immune complex formation
in anti-GBM disease, increasing antigen synthesis by
injured podocytes and facilitated by the capping and
shedding of antigen-antibody complexes into the sube-
pithelial space. Alternatively, anti-GBM antibodies might
arise after glomerular basement membrane damage that
occurs as a vasculitis involving the glomerular capil-
laries; damage to the glomerular basement membrane
might uncover “hidden antigens”, inducing the forma-
tion of antibodies to this membrane. This mechanism
may also explain anti-GBM disease after primary glo-
merulonephritis such as membranous nephropathy or
IgA glomerulonephritis [19].
Conclusion
Anti-GBM disease is a reversible cause of renal failure
if diagnosed and treated in the early stages of disease.
Recurrence following successful treatment is low and,
even in patients who have undergone transplantation,
there is a low likelihood of involvement in the trans-
planted kidney. Anti-GBM disease superimposed on
membranous nephropathy is very rare; only 16 cases
have been previously reported in the English language
literature. Despite treatment with immunosuppressive
agents and/or plasmapheresis, most of the patients
remained on hemodialysis. Knowing the significant
toxicity from treatment with cyclophosphomide and
corticosteroids, their role in treatment of patients with
anti-GBM disease and concurrent membranous
nephropathy in middle-aged patients with higher
serum creatinine levels and extensive renal involve-
ment on presentation is debatable and needs more
study. Patients who presented with a low serum creati-
nine, and were younger, were more likely to respond
to cytotoxic treatment and have a favorable outcome.
Advances in elucidating the structure of the glomerular
basement membrane antigen and the identification of
the pathogenic B and T cell epitopes, along with new
insights into the pathogenetic mechanisms at the cellu-
lar and molecular level, will facilitate the development
of targeted strategies for prevention, detection, and
treatment of human anti-GBM antibody glomerulone-
phritis [20]. It is presently unclear whether crescentic
transformation of underlying membranous nephropa-
thy implies an increase in the severity of the disease or
development of a second process. Optimal treatment
regimens need to be clarified and further research in
this area is necessary.
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